Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 62% ± 25% | |
glutamatergic neuron | 10 studies | 67% ± 20% | |
GABAergic neuron | 8 studies | 56% ± 19% | |
astrocyte | 8 studies | 34% ± 20% | |
retinal ganglion cell | 7 studies | 62% ± 25% | |
endothelial cell | 6 studies | 38% ± 18% | |
interneuron | 5 studies | 47% ± 29% | |
neuron | 3 studies | 37% ± 11% | |
GABAergic interneuron | 3 studies | 42% ± 15% | |
microglial cell | 3 studies | 46% ± 16% | |
cardiac muscle cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 41% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 94% | 1048.23 | 243 / 258 | 87% | 21.08 | 200 / 230 |
brain | 95% | 2202.39 | 2520 / 2642 | 63% | 5.80 | 442 / 705 |
thymus | 86% | 391.90 | 559 / 653 | 40% | 1.86 | 239 / 605 |
pancreas | 87% | 292.86 | 285 / 328 | 26% | 1.56 | 46 / 178 |
uterus | 85% | 462.20 | 145 / 170 | 21% | 1.03 | 97 / 459 |
breast | 22% | 67.93 | 101 / 459 | 60% | 6.43 | 671 / 1118 |
stomach | 67% | 216.33 | 239 / 359 | 6% | 0.46 | 16 / 286 |
kidney | 53% | 162.79 | 47 / 89 | 15% | 3.08 | 138 / 901 |
prostate | 12% | 31.90 | 29 / 245 | 53% | 2.29 | 268 / 502 |
blood vessel | 59% | 1082.82 | 783 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 47% | 473.14 | 679 / 1445 | 11% | 0.35 | 21 / 183 |
adipose | 47% | 299.47 | 571 / 1204 | 0% | 0 | 0 / 0 |
bladder | 14% | 38.71 | 3 / 21 | 27% | 2.15 | 138 / 504 |
muscle | 41% | 202.91 | 332 / 803 | 0% | 0 | 0 / 0 |
skin | 32% | 114.25 | 579 / 1809 | 2% | 0.13 | 8 / 472 |
heart | 31% | 142.65 | 271 / 861 | 0% | 0 | 0 / 0 |
intestine | 13% | 55.60 | 124 / 966 | 4% | 0.13 | 19 / 527 |
ovary | 8% | 40.93 | 15 / 180 | 8% | 0.13 | 34 / 430 |
lung | 2% | 5.31 | 13 / 578 | 11% | 0.43 | 128 / 1155 |
liver | 0% | 0 | 0 / 226 | 1% | 0.06 | 6 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015015 | Biological process | heparan sulfate proteoglycan biosynthetic process, enzymatic modification |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0017095 | Molecular function | heparan sulfate 6-O-sulfotransferase activity |
Gene name | HS6ST3 |
Protein name | Heparan-sulfate 6-O-sulfotransferase 3 (HS6ST-3) (EC 2.8.2.-) |
Synonyms | |
Description | FUNCTION: 6-O-sulfation enzyme which catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan sulfate. |
Accessions | Q8IZP7 ENST00000376705.4 |